https://www.selleckchem.com/products/tpx-0005.html
33,P less then 0.001) and inverse probability of treatment weighted propensity matching (HR=1.82,P less then 0.001). Conclusion In LT recipients with HCC presenting beyond MC, successful downstaging is predicted by wait time, alpha-fetoprotein response to LRT, and tumor burden, and results in excellent post-LT outcomes, justifying expansion of LT criteria. In LRT-NoDS patients, higher HCC-R compared to NoLRT-NoDS cannot be explained by clinicopathologic differences, suggesting a potentially aggravating role of LRT in patients with poor
Aimer
Commentaire
Partagez
